• Nougat
    link
    fedilink
    141 month ago

    It’s obviously going to be the next annual vaccination, like influenza has already been. I’m waiting for the next formulation to become available before I get my sixth round.

    • mox
      link
      fedilink
      English
      171 month ago

      Annual isn’t enough.

      Pooled estimates of VE of a primary vaccination cycle against laboratory-confirmed Omicron infection and symptomatic disease were both lower than 20% at 6 months from last dose administration. Booster doses restored VE to levels comparable to those acquired soon after the administration of the primary cycle. However, 9 months after booster administration, VE against Omicron was lower than 30% against laboratory-confirmed infection and symptomatic disease.

      https://pubmed.ncbi.nlm.nih.gov/37133863/

      • Nougat
        link
        fedilink
        51 month ago

        Oh, yeah, I meant to type “at least” annual. Apparently, my brain thinking about typing that was enough.

      • aramis87
        link
        fedilink
        41 month ago

        There’s some early evidence that more traditional vaccines (like NovaVax) may create longer protection than the mRNA vaccines (which seem to have more robust but shorter-lasting protectection).

        • mox
          link
          fedilink
          English
          41 month ago

          Interesting. Can you link some details?

    • BrightCandle
      link
      English
      41 month ago

      So far we have had between 4 and 6 waves a year, each of which is from a different variant. A variant breaks out and within 2 months its infected almost everyone at which point it dies down to become part of the background infections and a new variant takes over. There just isn’t enough time to make a vaccine and roll it out to deal with any of that problem. The vaccines that are getting rolled out now are for variant that disappeared 6 months ago. Nothing we do is going to be very effective against this until the vaccines are a lot more effective against potential future variants or we drastically reduce the number of hosts it gets to replicate in.